Change in the clinical development program for laquinimod

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Change in the clinical development program for laquinimod

LUND, Sweden, Feb. 19, 2014 (GLOBE NEWSWIRE) -- Active Biotech (NASDAQ OMX NORDIC: ACTI) today announces that its partner Teva Pharmaceuticals (NYSE: TEVA), has decided not to proceed to the randomization stage of the planned Libretto trial for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS), as the current design is no longer aligned with the regulatory strategy. This decision has no impact on other ongoing studies, such as CONCERTO, which are proceeding as planned, or on Teva Pharmaceuticals' plans to initiate clinical studies in Primary Progressive Multiple Sclerosis (PPMS).

About laquinimod (Nerventra ® )

Laquinimod (Nerventra®) is an oral, investigational, CNS-active immunomodulator with a novel mechanism of action primarily being developed for the treatment of relapsing-remitting MS (RRMS). The global Phase III clinical development program evaluating oral laquinimod in MS includes two pivotal studies, ALLEGRO and BRAVO. A third Phase III laquinimod trial, CONCERTO, is evaluating two doses of the investigational product (0.6mg and 1.2mg) in approximately 1,800 patients for up to 24 months. The primary outcome measure will be time to confirmed disability progression as measured by the EDSS. In addition to the MS clinical studies, laquinimod has concluded Phase II of development for Crohn's disease and lupus nephritis.

About Active Biotech

Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company with focus on autoimmune/inflammatory diseases and cancer. Projects in pivotal phase are laquinimod (Nerventra ® ), an orally administered small molecule with unique immunomodulatory properties for the treatment of multiple sclerosis, tasquinimod for prostate cancer and ANYARA primarily for the treatment of renal cell cancer. In addition, laquinimod Phase II clinical trials in Crohn's and Lupus has been concluded. The company also has one additional project in clinical development, the orally administered compound paquinimod (57-57) for systemic sclerosis. Please visit www.activebiotech.com for more information.

For further information:

Tomas Leanderson, President & CEO
Tel: +46 46 19 20 95
E-mail: tomas.leanderson@activebiotech.com
 Active Biotech AB (Corp. Reg. No. 556223-9227)
 Box 724, SE-220 07 Lund
 Tel: +46 46 19 20 00
 Fax: +46 46 19 11 00     
Hans Kolam, CFO
Tel: +46 46 19 20 44
E-mail: hans.kolam@activebiotech.com

Active Biotech is obligated to publish the information contained in this press release in accordance with the Swedish Securities Market Act. This information was provided to the media for publication 2:00 pm CET on February 19, 2014.

Change in the clinical development program for laquinimod http://hugin.info/1002/R/1763038/597342.pdf

HUG#1763038

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Service Pros Adds Windshield Repair to Lineup

Updated Category News Views 27

Revving Up the Service Engine Alright, folks, buckle up because Service Pros Auto Glass, our local go-to for windshield replacements, is cranking up their game. They're stepping into the windshield repair arena across Florida and South Carolina, aiming to save you a buck and keep you safe behind the wheel. That's a double win if you ask me. A Closer Look at the Details...

Continue Reading
Direxion Targets Anthropic's IPO with Bold New ETFs

Updated Category News Views 40

Anthropic's IPO Sparks Direxion's Latest ETF Moves Alright, folks, Anthropic's public filing for an IPO isn't just turning heads—it's lighting up the trading floor! Following this buzz, Direxion grabs its chance to unleash two new ETFs designed to seize on Anthropic's rollercoaster debut. We're talking about the Direxion Daily Anthropic Bull 2X ETF (ANTO) and the...

Continue Reading
Study Reveals Stark Disparities in Education Equity

Updated Category News Views 56

Are We Dropping the Ball on Future Talent? Listen, there’s a harsh truth screaming at us from the NWEA’s latest study, and it’s not pretty. We’re talking about a serious gap here, folks—one that shows lower-income kids are getting the short end of the stick in education yet again. When more than half of U.S. students come from lower-income families but only 20%...

Continue Reading
ChinaMarket: Linyi's Gateway for Global Buying Delegations

Updated Category News Views 0

Unlocking Trade Potential in Linyi, China Linyi, in Shandong province, has flipped the switch on the sourcing circuit with one powerful invite to global buying delegations. As we sit perched on the fence of an economically tangled world, China's open arms to Southeast and Central Asian buyers mark a significant shift towards more fluid trade connections. The Fourth Linyi...

Continue Reading
Scientology Ministers Train First Responders in Philippines

Updated Category News Views 43

Boots on the Ground: Scientology's Goodwill Tour In a world where chaos often reigns supreme, it's refreshing to see someone step up to support those who stare down danger daily. The Scientology Volunteer Ministers have taken it upon themselves to empower those on the front lines in the Philippines. From bustling Manila to the calmer waves of Davao City, these ministers...

Continue Reading
Jay Group Expands to Houston with New Fulfillment Hub

Updated Category News Views 67

Jay Group's Bold Move in the Logistics Arena In a no-holds-barred expansion, Jay Group's got themselves a brand new sprawling 250,000-square-foot fulfillment hub deep in the heart of Houston. Now, folks, this isn’t just another warehouse. We're talking a 3PL powerhouse that allows coast-to-coast delivery, hitting 90% of U.S. consumers in just a couple of days. If you're...

Continue Reading
Stora Enso Plans Bold Demerger; Bergslagets Skogar to List

Updated Category News Views 33

Stora Enso's Strategic Split: Bold Move or Risky Bet? There's something almost audacious about Stora Enso's decision to separate Bergslagets Skogar into its own publicly listed company. The board has given this demerger plan the green light, aiming to unravel a more refined operation out of Stora Enso's labyrinthine portfolio. It's a move that should have the suits on...

Continue Reading
Picturing Grief: Scoville's Visual Journey in Loss

Updated Category News Views 67

Let Images Speak the Unspeakable So, here's the deal: grief isn't something you can just wrap up in a neat little package of words. It's jagged, messy—and for many, untouchable by a traditional self-help roadmap. Enter Picturing Grief, the book by Michelle Scoville that smashes the mold with its arresting mix of imagery and reflection. Freshly on the scene courtesy of...

Continue Reading
Broadway.com Instagram Reaches Million Followers Milestone

Updated Category News Views 54

Broadway.com's Instagram Ascends to Iconic Status There it is, folks—Broadway.com's Instagram just threw down the gauntlet with a clean, million-follower milestone. That's right, a hefty chunk of people now have a front-row seat to Broadway's electric world, straight from their phones. If you're a Broadway buff or just a casual admirer of glitz and glam, these numbers...

Continue Reading
FuelCell Energy Faces Legal Scrutiny After Stock Plunge

Updated Category News Views 56

FuelCell Energy's Troubling Stock Dive FuelCell Energy's recent plummet isn't just a sobering reality for traders—it comes wrapped in controversy. With NASDAQ:FCEL suffering a 15.69% nosedive after revelations from their fiscal third-quarter results, the ticker’s future hangs precariously. Even for those who've braved the market’s caprices, seeing shares drop $2.68...

Continue Reading

Top 5 Most Recently Viewed Articles

Intalio Revolutionizes Education Administration Efficiency in Kuwait

Updated Category News Views 211

Transforming the Ministry of Higher Education in Kuwait Intalio, a leader in Intelligent Information Management, has joined forces with the Ministry of Higher Education to revolutionize the way correspondence and document handling occurs within the government. This collaboration is paving the way for enhanced efficiency and secure processes, making the operations smoother...

Continue Reading
Osisko Development Secures $24.2 Million in Funding via Placement

Updated Category News Views 108

Osisko Development’s Major Funding Achievement Osisko Development Corp. is thrilled to report the successful completion of the first tranche of its non-brokered private placement. This strategic move has garnered approximately US$24.2 million through the issuance of 13,426,589 units at a price of US$1.80 per unit. These funds mark a significant advancement for the...

Continue Reading
Progress Software Set to Acquire ShareFile for Real Growth

Updated Category News Views 99

Progress Software's Strategic Acquisition of ShareFile Progress Software (NASDAQ: PRGS) is making waves with its recent announcement about acquiring ShareFile, a unit of Cloud Software Group, for an impressive $875 million. This strategic decision is designed to enhance Progress' enterprise product lineup, especially in the rapidly changing world of cloud-enabled...

Continue Reading
Insights into the Growing Water Quality Sensor Market Dynamics

Updated Category News Views 217

Understanding the Water Quality Sensor Market Landscape The water quality sensor market, valued at USD 5.72 billion, is poised for significant growth. With projections indicating it will reach USD 9.47 billion by 2032 at a compound annual growth rate (CAGR) of 6.51%, the sector is increasingly vital. The surge in water pollution incidents and stringent regulatory...

Continue Reading
MSIG USA Triumphs with 2025 Celent Award for Innovation

Updated Category News Views 146

MSIG USA Triumphs: A 2025 Celent Model Insurer Award Winner MSIG USA proudly announces its recognition as a 2025 Celent Model Insurer Award recipient. This prestigious award honors the company's outstanding achievements in Legacy and Ecosystem Transformation. It reflects their commitment to modernization and strategic data utilization for driving profitable growth....

Continue Reading